0001209191-18-011401.txt : 20180220
0001209191-18-011401.hdr.sgml : 20180220
20180220170052
ACCESSION NUMBER: 0001209191-18-011401
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180217
FILED AS OF DATE: 20180220
DATE AS OF CHANGE: 20180220
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Alles Mark J
CENTRAL INDEX KEY: 0001538897
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34912
FILM NUMBER: 18625527
MAIL ADDRESS:
STREET 1: C/O CELGENE CORPORATION
STREET 2: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CELGENE CORP /DE/
CENTRAL INDEX KEY: 0000816284
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 222711928
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
BUSINESS PHONE: (908)673-9000
MAIL ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-02-17
0
0000816284
CELGENE CORP /DE/
CELG
0001538897
Alles Mark J
C/O CELGENE CORPORATION
86 MORRIS AVENUE
SUMMIT
NJ
07901
1
1
0
0
See Remarks
Common Stock
2018-02-17
4
M
0
7283
0.00
A
186187
D
Common Stock
2018-02-17
4
F
0
2060
95.26
D
184127
D
Common Stock
5924
I
401(k) Plan
Performance Stock Unit
2018-02-17
4
M
0
7283
0.00
D
Common Stock
7283
0
D
The performance stock units granted to the reporting person on February 13, 2018 vested and settled for shares of the Company's common stock.
Each performance stock unit represents a contingent right to receive one share of the Company's common stock.
The performance stock units were issued pursuant to the Company's 2017 Stock Incentive Plan.
Chief Executive Officer
/s/ Peter N. Kellogg, Attorney-in-Fact
2018-02-20